Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-01-06
2000-07-25
Lambkin, Deborah C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546106, A61K 3144, C07D21908
Patent
active
060937254
ABSTRACT:
Compounds and methods for inactivating pathogens in materials are described, including compositions and methods for inactivating pathogens in biological materials such as red blood cell preparations and plasma. The compounds and methods may be used to treat materials intended for in vitro or in vivo use, such as clinical testing or transfusion. The compounds are designed to specifically bind to and react with nucleic acid, and then to degrade to form breakdown products. The degradation reaction is preferably slower than the reaction with nucleic acid.
REFERENCES:
patent: 4337269 (1982-06-01), Berke et al.
patent: 4833165 (1989-05-01), Louderback
patent: 5399719 (1995-03-01), Wollowitz et al.
patent: 5559250 (1996-09-01), Cook et al.
patent: 5691371 (1997-11-01), Denny et al.
Derwent World Patent Index Record for Patent Family of DE 4444045, 1998.
Gourdie, et al., "DNA-Directed Alkylating Agents. 1. Structure-Activity Relationships for Acridine-Linked Aniline Mustards: Consequences of Varying the Reactivity of the Mustard," J. Med. Chem., vol. 33(4):1177-1186 (1990).
Cates, L.A. et al., (1984) "Phosphorous-Nitrogen Compounds. 24. Phosphoramide Mustard Carrier Derivatives" J. Med. Chem. 27(3):397-401.
Hanson et al., "Application of a Rapid Microplaque Assay for Determination of Human Immunodeficiency Virus Neutralizing Antibody Titers," J. Clin. Micro., (1990) 28:2030-2034.
Hogman et al., "Storage of saline-adenine-glucose-mannitol-suspended red cells in a new plastic container: polyvinylchloride plasticized with butyryl-n-trihexyl-citrate," Transfusion, (1991) 31:26-29.
Hogman et al., "Half-Strength Citrate CPD Combined with a New Additive Solution for Improved Storage of Red Blood Cells Suitable for Clinical Use," Vox Sang, (1993) 65:271-278.
Horowitz et al., "Solvent/Detergent-Treated Plasma: A virus-Inactivated Substitute for Fresh Frozen Plasma," Blood, (1992) 79:826-831.
Horowitz et al., "Inactivation of viruses in labile blood derivatives," Transfusion, (1985) 25:516-522.
LoGrippo et al., "Chemical and Combined Methods for Plasma Sterilization," Proceedings of the Sixth Congress of the International Society of Blood Transfusion, Bibliotheca Haematologica (Hollander, ed.) 1958, pp. 225-230.
Mattes et al., "GC-rich regions in genomes as targets for DNA alkylation" Carcinogenesis (1988) 9:2065-2072.
Mullman et al., "Guidelines for Prevention of Transmission of Human Immunodeficiency Virus and Hepatitis B Virus to Health-Care and Public-Safety Workers," Morbidity and Mortality Weekly Report, (1989) 38:3-6.
Peck et al., "Nitrogen Mustard Analogs of Antimalarial Drugs," J. Amer. Chem. Soc., (1959) 81:3984-3989.
Piquet et al., "Virus Inactivation of Fresh Frozen Plasma by a Solvent Detergent Procedure: Biological Results," Vox Sang. (1992) 63:251-256.
Popovic et al., "Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS," Science, (1984) 224:497-500.
Wagner et al., "Red cell alterations associated with virucidal methylene blue phototreatment," Transfusion, (1993) 33:30-36.
Wagner et al., "Differential sensitivities of viruses in red cell suspensions to methylene blue photosensitization," Transfusion, (1994) 34:521-526.
Beutler et al., "The Role of Bone Marrow Transplantation in the Treatment of Acute Leukemia in Remission," Blood, (1982) 59:1115-1117.
Cummings et al., "Determination of reactive nitrogen mustard anticancer drugs in plasma by high-performance liquid chromatography using derivatization" Anal. Chem. (1991) 63(15):1514-1519.
Davey et al., "The Effect of Prestorage Irradiation on Posttransfusion Red Cell Survival," Transfusion, (1992) 32:525-528.
Gravatt et al., "DNA-directed alkylating agents. 4. 4-anilinoquinoline-based minor groove directed aniline mustards" J. Med. Chem. (1991) 34:1552-1560.
Greenwalt et al., "Studies in Red Blood Cell Preservation," Vox Sang, (1990) 58:94-99.
Cook David
Matejovic Jan
Merritt John E.
Nerio Aileen
Rapoport Henry
Cerus Corporation
Lambkin Deborah C.
LandOfFree
Frangible compounds for pathogen inactivation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Frangible compounds for pathogen inactivation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Frangible compounds for pathogen inactivation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1336858